公司资料
Immunic 股价、新闻与催化剂
- 股票代码:
- IMUX
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- Germany
股票表现
16.46 USD (-0.24%)
收盘价
最后更新: 2026年8月24日
199M USD
市值
股价为何变动
As of Aug 24, 2026, IMUX was little changed and closed at $16.46. No new same-company headline was identified in the current news window.
公司概览
业务概览
Immunic is a biotechnology company focused on immune-mediated disease and small-molecule immunology. Its pipeline is aimed at inflammatory and autoimmune disorders.
所在地与行业分类
Headquartered in Germany and listed on NASDAQ as an ADR, Immunic has a global specialty-biopharma profile.
商业模式特征
The company depends on clinical data, target validation, and the ability to create a differentiated inflammation franchise.
生物医药行业定位
Immunic is a catalyst-sensitive immunology name whose stock reacts to early clinical and mechanistic signals.
未来催化剂
- Immunic’s catalysts are vidofludimus calcium and the autoimmune / neuroinflammation pipeline, where each update can change the company’s credibility quickly. The market still needs a stronger human-data story.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。